bufexamac has been researched along with Dermatitis, Eczematous in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aberer, W; Derhaschnig, J; Komericki, P; Kränke, B; Szolar-Platzer, C | 1 |
1 trial(s) available for bufexamac and Dermatitis, Eczematous
Article | Year |
---|---|
Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bufexamac; Child; Dermatitis, Allergic Contact; Eczema; Female; Humans; Male; Middle Aged; Patch Tests; Prevalence; Prognosis; Prospective Studies | 1997 |
1 other study(ies) available for bufexamac and Dermatitis, Eczematous
Article | Year |
---|---|
Parfenac.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Bufexamac; Eczema; Humans; Rats | 1974 |